text.skipToContent text.skipToNavigation

Hinweis nur für Kunden in Indonesien  Details anzeigen
Sind Sie ein Kunde aus Indonesien?
Kundensupport
Verbraucherbeschwerdestelle, PT DKSH Indonesia,

(Geschäftseinheit Performance Materials, Sales Support Team)

Adresse

Gebäude AIA Central, Ebene 39, Jl. Jend. Sudirman Kav. 48A, Jakarta Selatan, Indonesien

+62 21 2988 8557

[email protected]

Generaldirektion für Verbraucherschutz und Handelsordnung, Ministerium für Handel der Republik Indonesien
0853 1111 1010

Erfolg! Ihre Anfrage wurde an unser Vertriebsteam übermittelt.

Etwas ist schiefgelaufen! Bitte versuchen Sie es später erneut.

 Das Produkt wurde dem Angebot hinzugefügt

Pharmazeutische Inhaltsstoffe

Pharmazeutische Inhaltsstoffe

DKSH Discover offers pharmaceutical ingredients including APIs, excipients, and intermediates for drug development and formulation. Partner with trusted global suppliers to access high-quality, regulatory-compliant ingredients for oral, topical, and injectable pharma products.

Pharmazeutische Inhaltsstoffe

Wir haben 17 Elemente gefunden.

Filter
Angewendete FilterAlle löschen

Physical Form
sustainable
Musteranfrage
Kontaktdaten des Antragstellers
Vollständiger Name
Unternehmen
Position
Telefonnummer
Geschäftliche E-Mail-Adresse
Lieferadresse

Thank you. Your request has been sent.

Bestätigung der Angebotsanfrage

Möchten Sie mit einem bestehenden Angebot zusammenführen oder ein neues erstellen?

BILASTINE

Bilastine is a white to off-white crystalline powder that is sparingly soluble in methylene chloride and practically insoluble in acetone. It has an assay range of 98.0% to 102.0%.

 

Products still subject to third-party patent protection might be available solely for R&D purposes.

Bestätigung der Angebotsanfrage

Möchten Sie mit einem bestehenden Angebot zusammenführen oder ein neues erstellen?

TICLOPIDINE HCL

Refarmed Chemicals takes pride in providing the pharmaceutical industry with high-quality Ticlopidine Hydrochloride, an essential antiplatelet medication used to prevent strokes and other significant blood clots in patients who have experienced a stroke or transient ischemic attack (TIA). Manufactured under stringent GMP certification, our Ticlopidine Hydrochloride is presented in tablet form, with a strength of 250 mg ensuring consistent dosing and efficacy. Our Ticlopidine Hydrochloride acts by hindering platelet function, thereby diminishing the aggregation essential to blood clot formation. This preventive approach serves as a critical intervention in the management of clot-related disorders, significantly improving patient outcomes. Physicians typically recommend a starting dose of 250 mg administered twice daily, emphasizing that food intake during administration reduces gastrointestinal discomfort. Monitoring patient response allows for personalized treatment adjustments to optimize therapeutic benefits while considering safety profiles. As with all pharmaceuticals, we duly note possible side effects, ranging from mild gastrointestinal issues to less common, yet more severe reactions like neutropenia or liver impairment. This necessitates caution in prescribing to populations with liver disease, a history of bleeding disorders, or inflammatory bowel disease. Continuous patient monitoring and drug interaction vigilance are paramount, especially concerning commonly used medications such as aspirin and warfarin. Compliant storage conditions entail keeping the Ticlopidine Hydrochloride tablets at room temperature (15°C to 30°C), shielded from light and moisture to maintain product integrity. Ticlopidine Hydrochloride is supplied as a generic medication, ensuring affordability without compromising quality. Embracing our commitment to patient safety and treatment adherence, we underline the significance of medical guidance before initiating or discontinuing use, with particular respect to special populations like pregnant or breastfeeding women. Rest assured, our partnership with the DKSH Group underlines a shared vision for growth and delivery of quality healthcare solutions that spans across Asia and beyond, cementing our position as a trusted supplier in the pharmaceutical landscape.

 

Products still subject to third-party patent protection might be available solely for R&D purposes.

Bestätigung der Angebotsanfrage

Möchten Sie mit einem bestehenden Angebot zusammenführen oder ein neues erstellen?

THONZYLAMINE HCL

**Thonzylamine HCl: Efficacious Antihistamine for Allergic Relief** Thonzylamine HCl, offered under the REFARMED CHEMICALS brand, is a potent first-generation antihistamine tailored for the pharmaceutical industry's demand for reliable and effective allergy symptomatic treatment. This compound, classified under the alkylamine class, serves as a crucial ingredient for medications formulated to alleviate discomfort from common allergic reactions such as hay fever, allergic rhinitis, and hives. As an active pharmaceutical ingredient (API), it plays a significant role in delivering relief to countless individuals affected by these prevalent conditions. Primarily presented as a white to slightly yellowish crystalline powder, Thonzylamine HCl upholds a high standard of purity, with an assay value ranging from 98.5% to 101.0%. Its manufacturing process is governed by stringent EU GMP certifications, ensuring that every batch meets the requirements for quality and consistency—attributes of paramount importance for our corporate clientele. Thonzylamine HCl works by effectively intercepting histamine's action—an organic compound responsible for numerous allergic symptoms. By blocking histamine receptors, this API diminishes the intensity of effects such as sneezing, runny nose, and itchy eyes, dramatically improving quality of life for allergy sufferers. Administered orally, the recommended dosage for adults and children over the age of 12 is between 50-100 mg, three to four times daily, as prescribed by healthcare professionals. Furthermore, precautions are advised in patients with liver or kidney disease, and the substance should be avoided by individuals with sensitivities to its components or conditions like acute asthma, narrow-angle glaucoma, or urinary retention. Additionally, users should be cautious about engaging in activities requiring cognitive sharpness, such as operating machinery or driving, as Thonzylamine HCl has sedative properties that may impair alertness. Our website offers complete details, including the chemical structure (2-[(2-Dimethylaminoethyl)(p-methoxybenzyl)amino]pyridine hydrochloride) and analytical specifications that reveal its physical and chemical properties. Rest assured, partnering with our company provides you with access to an essential product that epitomizes the excellence and dedication to the pharmaceutical supply chain, delivering health and wellness to the community.

 

Products still subject to third-party patent protection might be available solely for R&D purposes.

Bestätigung der Angebotsanfrage

Möchten Sie mit einem bestehenden Angebot zusammenführen oder ein neues erstellen?

PROCATEROL HCL HEMIHYDRATE

Procaterol HCl Hemihydrate: A Specialized Compound for Asthma and COPD Management In an industry where efficacy and patient safety are paramount, REFARMED CHEMICALS' Procaterol HCl Hemihydrate emerges as a vital pharmaceutical ingredient. This beta-2 adrenergic receptor agonist plays a crucial role in the medical management of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). By targeting bronchial smooth muscles, it facilitates breathing by promoting bronchodilation and reducing inflammation, a testament to its pharmacological prowess. The chemical composition of Procaterol HCl Hemihydrate, C11H16Cl2N2O·0.5H2O, is synthesized to achieve a precise molecular weight of 265.14 g/mol, ensuring the utmost purity and effectiveness. Appearing as a white to off-white crystalline powder, it maintains its integrity as slightly soluble in both water and organic solvents, indicative of its carefully regulated physical properties. Developed with strict adherence to global standards, this product is backed by comprehensive documentation such as EU DMF and JDMF, and is certified under EU GMP, underscoring REFARMED CHEMICALS' commitment to quality. The substance exhibits a melting point of ≤195°C and a clear aqueous solution at 3.3%, ensuring its stability and consistency in formulation. Safety is paramount; thus, precautions are advised for patients with pre-existing cardiovascular conditions, and careful monitoring is recommended to prevent adverse effects such as tachycardia or tremors. With individualized dosage, delivered usually through inhalation methods like metered-dose inhalers or dry powder inhalers, this pharmaceutical ingredient provides a targeted approach to managing respiratory ailments. REFARMED CHEMICALS is proud to offer a product that meets the rigorous demands of the pharmaceutical industry while improving the quality of life for patients globally. Contraindicated only in those with a known hypersensitivity to beta-2 adrenergic agonists or a recent myocardial infarction, Procaterol HCl Hemihydrate is a testament to the company's mission—delivering growth in the pursuit of health care advancements.

 

Products still subject to third-party patent protection might be available solely for R&D purposes.

Entschuldigung! Dieses Feld darf nicht leer sein.
Entschuldigung! Dieses Feld darf nicht leer sein.
Entschuldigung! Dieses Feld darf nicht leer sein.
Entschuldigung! Dieses Feld darf nicht leer sein.
Entschuldigung! Dieses Feld darf nicht leer sein.
Entschuldigung! Dieses Feld darf nicht leer sein.
Entschuldigung! Dieses Feld darf nicht leer sein.
Entschuldigung! Dieses Feld darf nicht leer sein.
Entschuldigung! Dieses Feld darf nicht leer sein.
Entschuldigung! Dieses Feld darf nicht leer sein.
Entschuldigung! Dieses Feld darf nicht leer sein.
*Erforderlich

Vielen Dank für Ihre Anfrage.

Wir werden Sie innerhalb weniger Werktage kontaktieren.

Product quantity has been updated.